相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacokinetics of Mirabegron, a β3-Adrenoceptor Agonist for Treatment of Overactive Bladder, in Healthy East Asian Subjects
Hiromi Iitsuka et al.
CLINICAL THERAPEUTICS (2015)
Involvement of β3-adrenoceptors in the inhibitory control of cholinergic activity in human bladder: Direct evidence by [3H]-acetylcholine release experiments in the isolated detrusor
Gianluigi D'Agostino et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
A Randomized Controlled Study of the Efficacy of Tamsulosin Monotherapy and its Combination with Mirabegron for Overactive Bladder Induced by Benign Prostatic Obstruction
Koji Ichihara et al.
JOURNAL OF UROLOGY (2015)
The Beta-3 Adrenoceptor Agonist, Mirabegron Relaxes Isolated Prostate From Human and Rabbit: New Therapeutic Indication?
Fabiano B. Calmasini et al.
PROSTATE (2015)
Phase III, randomised, double-blind, placebo-controlled study of the 3-adrenoceptor agonist mirabegron, 50mg once daily, in Japanese patients with overactive bladder
Osamu Yamaguchi et al.
BJU INTERNATIONAL (2014)
Pharmacokinetics of Mirabegron, a β3-Adrenoceptor Agonist for Treatment of Overactive Bladder, in Healthy Japanese Male Subjects: Results from Single- and Multiple-Dose Studies
Hiromi Iitsuka et al.
CLINICAL DRUG INVESTIGATION (2014)
The Efficacy of PDE5 Inhibitors Alone or in Combination with Alpha-Blockers for the Treatment of Erectile Dysfunction and Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis
Huilei Yan et al.
JOURNAL OF SEXUAL MEDICINE (2014)
Do β-adrenoceptor agonists induce homologous or heterologous desensitization in rat urinary bladder?
Martin C. Michel
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2014)
The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
Adam J. Pawson et al.
NUCLEIC ACIDS RESEARCH (2014)
Purinergic signalling in the urinary tract in health and disease
Geoffrey Burnstock
PURINERGIC SIGNALLING (2014)
The Odd Sibling: Features of β3-Adrenoceptor Pharmacology
Hana Cernecka et al.
MOLECULAR PHARMACOLOGY (2014)
Soluble Guanylyl Cyclase (sGC) Degradation and Impairment of Nitric Oxide-Mediated Responses in Urethra from Obese Mice: Reversal by the sGC Activator BAY 60-2770
Eduardo C. Alexandre et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: ENZYMES
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: G PROTEIN-COUPLED RECEPTORS
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Different β-adrenoceptor subtypes coupling to cAMP or NO/cGMP pathways: implications in the relaxant response of rat conductance and resistance vessels
N. Flacco et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
The novel β3-adrenoceptor agonist mirabegron reduces carbachol-induced contractile activity in detrusor tissue from patients with bladder outflow obstruction with or without detrusor overactivity
Julie Svalo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
The new radioligand [3H]-L 748,337 differentially labels human and rat β3-adrenoceptors
Jan-Peter van Wieringen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Randomized Double-blind, Active-controlled Phase 3 Study to Assess 12-Month Safety and Efficacy of Mirabegron, a β3-Adrenoceptor Agonist, in Overactive Bladder
Christopher R. Chapple et al.
EUROPEAN UROLOGY (2013)
Evaluation and Treatment of Lower Urinary Tract Symptoms in Older Men
P. Abrams et al.
JOURNAL OF UROLOGY (2013)
In vitro and in vivo pharmacological profile of the selective β3-adrenoceptor agonist mirabegron in rats
Toshiki Hatanaka et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2013)
Fenoterol functionally activates the β3-adrenoceptor in human urinary bladder, comparison with rat and mouse: Implications for drug discovery
Stefano Palea et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction
Debra E. Irwin et al.
BJU INTERNATIONAL (2011)
Update on AUA Guideline on the Management of Benign Prostatic Hyperplasia
Kevin T. McVary et al.
JOURNAL OF UROLOGY (2011)
Guidelines for reporting experiments involving animals: the ARRIVE guidelines
J. C. McGrath et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Carol Kilkenny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
The tricyclic antidepressants amitriptyline, nortriptyline and imipramine are weak antagonists of human and rat α1B-adrenoceptors
F. D. Nojimoto et al.
NEUROPHARMACOLOGY (2010)
Involvement of β3-adrenoceptors in mouse urinary bladder function: Role in detrusor muscle relaxation and micturition reflex
Aurore Deba et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Catecholamines Relax Detrusor through beta(2)-Adrenoceptors in Mouse and beta(3)-Adrenoceptors in Man
Melinda Wuest et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Comparative efficacy assessment of tamsulosin vs. tamsulosin plus tadalafil in the treatment of LUTS/BPH.: Pilot study
Amado Bechara et al.
JOURNAL OF SEXUAL MEDICINE (2008)
The β3-Adrenoceptor Agonist 4-[[(Hexylamino)carbonyl]amino]-N-[4-[2-[[(2S)-2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]phenyl]-benzenesulfonamide (L755507) and Antagonist (S)-N-[4-[2-[[3-[3-(Acetamidomethyl)phenoxy]-2-hydroxypropyl]amino]ethyl]phenyl] benzenesulfonamide (L748337) Activate Different Signaling Pathways in Chinese Hamster Ovary-K1 Cells Stably Expressing the Human β3-Adrenoceptor
Masaaki Sato et al.
MOLECULAR PHARMACOLOGY (2008)
Effect of (R)-2-(2-aminothiazol-4-yl)-4′-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} acetanilide (YM178), a novel selective β3-adrenoceptor agonist, on bladder function
Toshiyuki Takasu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Age related changes in the functional, biochemical and molecular properties of α1-adenoceptors in the rat genitourinary tract
Makoto Yono et al.
JOURNAL OF UROLOGY (2006)
Mixed β3-adrenoceptor agonist and α1-adrenoceptor antagonist properties of nebivolol in rat thoracic aorta
B Rozec et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
α1-, α2- and β-adrenoceptors in the urinary bladder, urethra and prostate
MC Michel et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Involvement of cyclic AMP-dependent and -independent mechanisms in the relaxation of rat detrusor muscle via β-adrenoceptors
H Uchida et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Does cyclic AMP mediate rat urinary bladder relaxation by isoproterenol?
EP Frazier et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Differential antagonism by conotoxin p-TIA of contractions mediated by distinct α1-adrenoceptor subtypes in rat vas deferens, spleen and aorta
V Lima et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
The N terminus of the human α1D-adrenergic receptor prevents cell surface expression
C Hague et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Functional characterization of β-adrenoceptor subtypes in the canine and rat lower urinary tract
H Takeda et al.
JOURNAL OF UROLOGY (2003)
N-terminal truncation of human α1D-adrenoceptors increases expression of binding sites but not protein
AS Pupo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
The functional role of beta-adrenoceptor subtypes in mediating relaxation of pig urethral smooth muscle
T Yamanishi et al.
JOURNAL OF UROLOGY (2003)
Biochemistry and pharmacology of epitope-tagged α1-adrenergic receptor subtypes
A Vicentic et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Relaxant effects of isoproterenol and selective beta 3-adrenoceptor agonists on normal, low compliant and hyperreflexic human bladders
Y Igawa et al.
JOURNAL OF UROLOGY (2001)
分享论文
